Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors

The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk factor. Furthermore, six iris color predicting...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Investigative ophthalmology & visual science Ročník 64; číslo 13; s. 45
Hlavní autoři: Wu, Mike, Yavuzyiğitoğlu, Serdar, Brosens, Erwin, Ramdas, Wishal D., Kiliç, Emine
Médium: Journal Article
Jazyk:angličtina
Vydáno: The Association for Research in Vision and Ophthalmology 30.10.2023
Témata:
ISSN:1552-5783, 0146-0404, 1552-5783
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk factor. Furthermore, six iris color predicting SNPs have been discovered (IrisPlex). Interestingly, two of these (rs129138329 and rs12203592) are also UM-risk factors. We collected worldwide incidence data of OM and investigated its correlations with iris color, IrisPlex SNPs, and UM-risk SNPs.PurposeThe worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk factor. Furthermore, six iris color predicting SNPs have been discovered (IrisPlex). Interestingly, two of these (rs129138329 and rs12203592) are also UM-risk factors. We collected worldwide incidence data of OM and investigated its correlations with iris color, IrisPlex SNPs, and UM-risk SNPs.Cases of OM, as defined by the International Classification of Diseases Oncology C69 (eye), 8720/3 to 8790/3 (malignant melanoma), and 8000 to 8005 (malignant neoplasm), between 1988 and 2012, were extracted from the Cancer Incidence in Five Continents. Incidence rates were age-standardized and their trends were analyzed with joinpoint regression and age period cohort modeling. Frequencies for each country of iris color, IrisPlex SNPs, and UM-risk SNPs were collected from the literature.MethodsCases of OM, as defined by the International Classification of Diseases Oncology C69 (eye), 8720/3 to 8790/3 (malignant melanoma), and 8000 to 8005 (malignant neoplasm), between 1988 and 2012, were extracted from the Cancer Incidence in Five Continents. Incidence rates were age-standardized and their trends were analyzed with joinpoint regression and age period cohort modeling. Frequencies for each country of iris color, IrisPlex SNPs, and UM-risk SNPs were collected from the literature.Incidence rates were generally ≥8.0 cases per million person-years in Northern Europe, Western Europe, and Oceania; 2.0 to 7.9 in North America, Eastern Europe, and Southern Europe; and <2.0 in South America, Asia, and Africa. OM incidence correlated with latitude (r = 0.77, P ≤ 0.001) and is expressed as a north-to-south decreasing gradient in Europe. SNP rs12913832 correlated with OM incidence (r = 0.83, P ≤ 0.001), blue iris color (r = 0.56, P ≤ 0.05), green iris color (r = 0.51, P ≤ 0.05), and brown iris color (r = -0.64, P ≤ 0.01). Trends were stable for most countries (28/35).ResultsIncidence rates were generally ≥8.0 cases per million person-years in Northern Europe, Western Europe, and Oceania; 2.0 to 7.9 in North America, Eastern Europe, and Southern Europe; and <2.0 in South America, Asia, and Africa. OM incidence correlated with latitude (r = 0.77, P ≤ 0.001) and is expressed as a north-to-south decreasing gradient in Europe. SNP rs12913832 correlated with OM incidence (r = 0.83, P ≤ 0.001), blue iris color (r = 0.56, P ≤ 0.05), green iris color (r = 0.51, P ≤ 0.05), and brown iris color (r = -0.64, P ≤ 0.01). Trends were stable for most countries (28/35).OM incidence is highest in populations of European ancestry and lowest in populations of Asian and African ancestry. Overall, trends are stable, and the spatial correlation among OM incidence, iris color, and rs12913832 may support the role of pigmentation-related risk factors in OM development.ConclusionsOM incidence is highest in populations of European ancestry and lowest in populations of Asian and African ancestry. Overall, trends are stable, and the spatial correlation among OM incidence, iris color, and rs12913832 may support the role of pigmentation-related risk factors in OM development.
AbstractList The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk factor. Furthermore, six iris color predicting SNPs have been discovered (IrisPlex). Interestingly, two of these (rs129138329 and rs12203592) are also UM-risk factors. We collected worldwide incidence data of OM and investigated its correlations with iris color, IrisPlex SNPs, and UM-risk SNPs.PurposeThe worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris color and four specific single-nucleotide-polymorphisms (SNPs) have been identified as a UM-risk factor. Furthermore, six iris color predicting SNPs have been discovered (IrisPlex). Interestingly, two of these (rs129138329 and rs12203592) are also UM-risk factors. We collected worldwide incidence data of OM and investigated its correlations with iris color, IrisPlex SNPs, and UM-risk SNPs.Cases of OM, as defined by the International Classification of Diseases Oncology C69 (eye), 8720/3 to 8790/3 (malignant melanoma), and 8000 to 8005 (malignant neoplasm), between 1988 and 2012, were extracted from the Cancer Incidence in Five Continents. Incidence rates were age-standardized and their trends were analyzed with joinpoint regression and age period cohort modeling. Frequencies for each country of iris color, IrisPlex SNPs, and UM-risk SNPs were collected from the literature.MethodsCases of OM, as defined by the International Classification of Diseases Oncology C69 (eye), 8720/3 to 8790/3 (malignant melanoma), and 8000 to 8005 (malignant neoplasm), between 1988 and 2012, were extracted from the Cancer Incidence in Five Continents. Incidence rates were age-standardized and their trends were analyzed with joinpoint regression and age period cohort modeling. Frequencies for each country of iris color, IrisPlex SNPs, and UM-risk SNPs were collected from the literature.Incidence rates were generally ≥8.0 cases per million person-years in Northern Europe, Western Europe, and Oceania; 2.0 to 7.9 in North America, Eastern Europe, and Southern Europe; and <2.0 in South America, Asia, and Africa. OM incidence correlated with latitude (r = 0.77, P ≤ 0.001) and is expressed as a north-to-south decreasing gradient in Europe. SNP rs12913832 correlated with OM incidence (r = 0.83, P ≤ 0.001), blue iris color (r = 0.56, P ≤ 0.05), green iris color (r = 0.51, P ≤ 0.05), and brown iris color (r = -0.64, P ≤ 0.01). Trends were stable for most countries (28/35).ResultsIncidence rates were generally ≥8.0 cases per million person-years in Northern Europe, Western Europe, and Oceania; 2.0 to 7.9 in North America, Eastern Europe, and Southern Europe; and <2.0 in South America, Asia, and Africa. OM incidence correlated with latitude (r = 0.77, P ≤ 0.001) and is expressed as a north-to-south decreasing gradient in Europe. SNP rs12913832 correlated with OM incidence (r = 0.83, P ≤ 0.001), blue iris color (r = 0.56, P ≤ 0.05), green iris color (r = 0.51, P ≤ 0.05), and brown iris color (r = -0.64, P ≤ 0.01). Trends were stable for most countries (28/35).OM incidence is highest in populations of European ancestry and lowest in populations of Asian and African ancestry. Overall, trends are stable, and the spatial correlation among OM incidence, iris color, and rs12913832 may support the role of pigmentation-related risk factors in OM development.ConclusionsOM incidence is highest in populations of European ancestry and lowest in populations of Asian and African ancestry. Overall, trends are stable, and the spatial correlation among OM incidence, iris color, and rs12913832 may support the role of pigmentation-related risk factors in OM development.
Author Yavuzyiğitoğlu, Serdar
Kiliç, Emine
Ramdas, Wishal D.
Wu, Mike
Brosens, Erwin
Author_xml – sequence: 1
  givenname: Mike
  surname: Wu
  fullname: Wu, Mike
  organization: Department of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands
– sequence: 2
  givenname: Serdar
  surname: Yavuzyiğitoğlu
  fullname: Yavuzyiğitoğlu, Serdar
  organization: Department of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands
– sequence: 3
  givenname: Erwin
  surname: Brosens
  fullname: Brosens, Erwin
  organization: Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands
– sequence: 4
  givenname: Wishal D.
  surname: Ramdas
  fullname: Ramdas, Wishal D.
  organization: Department of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
– sequence: 5
  givenname: Emine
  surname: Kiliç
  fullname: Kiliç, Emine
  organization: Department of Ophthalmology, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Department of Clinical Genetics, Erasmus MC University Medical Center, Rotterdam, The Netherlands, Erasmus MC Cancer Institute, Erasmus MC University Medical Center, Rotterdam, The Netherlands
BookMark eNp1UctKAzEUDVLRVl26z9LN1GTymMxKpPgoKBVRupKQyWQ0OpPUZKr496a2iAqu7uOce-5rBAbOOwPAIUZjjHlxbP1bHHM6xmRM2RYYYsbyjBWCDH74u2AU4zNCOcY52gG7pChRXtBiCB7mPrT1u60NnDqdjNMG-gbO9LJVAV6bVjnfKahcDSc-hBT31js4t_0TvLGPnXH9Vya7XUGmhrc2vsBzpXsf4j7YblQbzcHG7oH787O7yWV2NbuYTk6vMk046zOhGq1FJZqGCKFLVnGES15pjfO6LCsuasJRQY1KKON5blilBC4EaxhLhZTsgZO17mJZdabWaaigWrkItlPhQ3pl5W_E2Sf56N8kRhwXnIikcLRRCP51aWIvOxu1adP6xi-jzIWgWFBR8kTN1lQdfIzBNN99MJKrn8jVTySnEhNJWeKTP3xt1zdLo9j2n6pPMtKT3g
CitedBy_id crossref_primary_10_1016_j_ophtha_2025_04_018
crossref_primary_10_3389_fphar_2024_1466896
crossref_primary_10_3390_jcm14124058
crossref_primary_10_1016_j_apjo_2024_100060
crossref_primary_10_3389_fmed_2025_1494925
crossref_primary_10_1038_s41598_025_88625_w
crossref_primary_10_3390_cancers17122057
crossref_primary_10_1038_s41418_025_01469_9
crossref_primary_10_1167_iovs_66_5_38
crossref_primary_10_1111_aos_17493
crossref_primary_10_1111_aos_17492
crossref_primary_10_1016_j_ophtha_2024_09_001
crossref_primary_10_1016_j_ajoc_2024_102162
crossref_primary_10_1167_iovs_66_2_24
crossref_primary_10_1111_aos_17449
crossref_primary_10_32604_or_2024_048437
crossref_primary_10_1186_s40662_025_00430_8
crossref_primary_10_1016_j_xhgg_2025_100465
crossref_primary_10_1093_oncolo_oyae112
crossref_primary_10_3390_cancers16193346
crossref_primary_10_3390_biomedicines12081772
crossref_primary_10_1016_j_ajo_2025_03_002
crossref_primary_10_1007_s40135_025_00334_9
crossref_primary_10_1111_pcmr_70006
crossref_primary_10_1007_s13273_024_00466_2
crossref_primary_10_3389_pore_2025_1612085
crossref_primary_10_3390_cancers16050931
crossref_primary_10_1007_s11864_025_01330_8
Cites_doi 10.1038/eye.2015.51
10.1111/aos.v99.8
10.1186/s40942-020-00261-w
10.1038/s41525-017-0008-5
10.1016/j.ajo.2007.10.022
10.1001/archopht.122.2.167
10.1038/s41467-020-16276-8
10.1111/aos.2013.91.issue-7
10.1167/iovs.15-16532
10.1159/000480640
10.1002/ijc.v105:1
10.1080/09286580591000836
10.1001/jamaophthalmol.2020.0531
10.1016/j.ophtha.2021.11.011
10.3390/ijms21197172
10.1016/j.ajhg.2016.09.008
10.1097/CMR.0000000000000641
10.1016/j.ophtha.2008.10.008
10.1002/(ISSN)1097-0142
10.1038/s41586-020-2308-7
10.1016/j.ophtha.2005.04.020
10.1016/j.fsigen.2011.07.009
10.1016/j.fsigen.2012.07.005
10.3389/fmed.2022.926034
10.17219/acem/146581
10.1002/ijc.v137.9
10.1159/000492391
10.1001/archopht.124.1.54
10.1016/S0002-9394(02)02288-2
10.1177/0962280206070621
10.1093/jnci/djab167
10.1136/bjo.2009.157933
10.1002/ijc.20690
10.1038/nature15393
10.1200/GO.20.00294
10.1111/aos.1985.63.issue-6
10.1038/srep31191
10.1111/imig.2002.40.issue-5
10.1016/j.ophtha.2007.01.032
10.1136/bjophthalmol-2019-313977
10.1371/journal.pgen.1009201
10.1097/CMR.0000000000000375
10.1007/s00417-021-05317-7
10.1186/s12963-018-0177-1
ContentType Journal Article
Copyright Copyright 2023 The Authors 2023
Copyright_xml – notice: Copyright 2023 The Authors 2023
CorporateAuthor on behalf of the Rotterdam Ocular Melanoma Study Group (ROMS)
CorporateAuthor_xml – name: on behalf of the Rotterdam Ocular Melanoma Study Group (ROMS)
DBID AAYXX
CITATION
7X8
5PM
DOI 10.1167/iovs.64.13.45
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Worldwide Incidence of Ocular Melanoma
EISSN 1552-5783
ExternalDocumentID PMC10617638
10_1167_iovs_64_13_45
GroupedDBID ---
18M
2WC
34G
39C
5GY
5RE
AAYXX
ACGFO
ACNCT
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GROUPED_DOAJ
GX1
N9A
OK1
P2P
RPM
SJN
TR2
TRV
W8F
WH7
WOQ
WOW
7X8
5PM
ID FETCH-LOGICAL-c365t-8afcc8b8ff388c95b60196bcc12d99b68d36074ea88c5622e5ba81785f55cc843
ISICitedReferencesCount 30
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001169492700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1552-5783
0146-0404
IngestDate Thu Aug 21 18:36:48 EDT 2025
Thu Sep 04 19:00:10 EDT 2025
Tue Nov 18 22:06:55 EST 2025
Sat Nov 29 03:46:07 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13
Language English
License http://creativecommons.org/licenses/by/4.0
This work is licensed under a Creative Commons Attribution 4.0 International License.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c365t-8afcc8b8ff388c95b60196bcc12d99b68d36074ea88c5622e5ba81785f55cc843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1167/iovs.64.13.45
PMID 37902747
PQID 2884184896
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10617638
proquest_miscellaneous_2884184896
crossref_primary_10_1167_iovs_64_13_45
crossref_citationtrail_10_1167_iovs_64_13_45
PublicationCentury 2000
PublicationDate 20231030
PublicationDateYYYYMMDD 2023-10-30
PublicationDate_xml – month: 10
  year: 2023
  text: 20231030
  day: 30
PublicationDecade 2020
PublicationTitle Investigative ophthalmology & visual science
PublicationYear 2023
Publisher The Association for Research in Vision and Ophthalmology
Publisher_xml – name: The Association for Research in Vision and Ophthalmology
References Bray (bib39) 2017
Royer-Bertrand (bib5) 2016; 99
WHO (bib54) 2013
Walsh (bib14) 2012; 6
Forman (bib38) 2013
Templeton (bib42) 1967; 20
Curado (bib37) 2007
Aronow (bib23) 2018; 4
Stalker (bib62) 2002; 40
Vajdic (bib25) 2003; 105
Tomizuka (bib16) 2017; 27
Shields (bib9) 2007; 105
Altshuler (bib52) 2015; 526
Weis (bib2) 2006; 124
Houtzagers (bib55) 2020; 21
Phillpotts (bib58) 1995; 87
Parkin (bib35) 1997
Mobuchon (bib12) 2022; 114
Teikari (bib20) 1985; 63
Thomsen (bib10) 2020; 30
Hu (bib34) 2008; 145
Karczewski (bib61) 2020; 581
Weis (bib3) 2009; 116
Virgili (bib28) 2020; 138
Liu (bib18) 2013; 91
Park (bib17) 2015; 56
Gill (bib22) 2022; 9
Parkin (bib36) 2002
Shields (bib59) 2015; 29
Ferlay (bib40) 2017
Mobuchon (bib11) 2017; 2
Stang (bib15) 2005; 114
Chang (bib1) 1998; 83
Statistics ABo (bib49) 2022
Shah (bib4) 2005; 112
Day, Jennifer Cheeseman (bib48) 1996
Baily (bib26) 2019; 5
Ghazawi (bib29) 2020; 104
Ferlay (bib43) 2018
Nowak (bib30) 2022; 31
Division UNS (bib46) 1999
Wierenga (bib56) 2022; 129
Ghazawi (bib24) 2019; 103
Omar (bib47) 2001
Alfaar (bib27) 2022; 260
Smidt-Nielsen (bib21) 2021; 99
Yu (bib33) 2003; 135
Shields (bib8) 2004; 122
Walsh (bib57) 2013; 7
Google (bib53) 2023
Triay (bib32) 2009; 93
Lucena (bib41) 2020; 6
Ferguson (bib13) 2016; 6
Omonisi (bib60) 2020; 6
Johansson (bib6) 2020; 11
Bray (bib44) 2015; 137
Virgili (bib19) 2007; 114
Cisarova (bib7) 2020; 16
Bray (bib45) 2017
Isager (bib31) 2005; 12
Morris (bib51) 2018; 16
Tiwari (bib50) 2006; 15
References_xml – volume: 29
  start-page: 1027
  issue: 8
  year: 2015
  ident: bib59
  article-title: Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture
  publication-title: Eye (Lond)
  doi: 10.1038/eye.2015.51
– volume: 99
  start-page: e1474
  issue: 8
  year: 2021
  ident: bib21
  article-title: Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.v99.8
– volume: 6
  start-page: 51
  issue: 1
  year: 2020
  ident: bib41
  article-title: Epidemiology of uveal melanoma in Brazil
  publication-title: Int J Retina Vitreous
  doi: 10.1186/s40942-020-00261-w
– volume-title: Cancer Incidence in Five Continents
  year: 2017
  ident: bib45
  article-title: Chapter 1: Introduction and guide to this volume
– volume: 2
  start-page: 5
  year: 2017
  ident: bib11
  article-title: A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus
  publication-title: NPJ Genom Med
  doi: 10.1038/s41525-017-0008-5
– volume: 145
  start-page: 418
  issue: 3
  year: 2008
  ident: bib34
  article-title: Population-based incidence of conjunctival melanoma in various races and ethnic groups and comparison with other melanomas
  publication-title: Am J Ophthalmol
  doi: 10.1016/j.ajo.2007.10.022
– volume: 122
  start-page: 167
  issue: 2
  year: 2004
  ident: bib8
  article-title: Conjunctival nevi: clinical features and natural course in 410 consecutive patients
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.122.2.167
– volume: 11
  start-page: 2408
  issue: 1
  year: 2020
  ident: bib6
  article-title: Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-16276-8
– volume: 91
  start-page: e583
  issue: 7
  year: 2013
  ident: bib18
  article-title: Mortality from uveal melanoma treated by enucleation – a 16-year survey in Taiwan
  publication-title: Acta Ophthalmol
  doi: 10.1111/aos.2013.91.issue-7
– volume: 56
  start-page: 4719
  issue: 8
  year: 2015
  ident: bib17
  article-title: Nationwide incidence of ocular melanoma in South Korea by using the National Cancer Registry Database (1999-2011)
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.15-16532
– volume: 4
  start-page: 145
  issue: 3
  year: 2018
  ident: bib23
  article-title: Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013)
  publication-title: Ocul Oncol Pathol
  doi: 10.1159/000480640
– volume: 105
  start-page: 117
  issue: 1
  year: 2003
  ident: bib25
  article-title: Incidence of ocular melanoma in Australia from 1990 to 1998
  publication-title: Int J Cancer
  doi: 10.1002/ijc.v105:1
– volume: 12
  start-page: 223
  issue: 4
  year: 2005
  ident: bib31
  article-title: Uveal and conjunctival malignant melanoma in Denmark, 1943-97: incidence and validation study
  publication-title: Ophthalmic Epidemiol
  doi: 10.1080/09286580591000836
– volume: 138
  start-page: 601
  issue: 6
  year: 2020
  ident: bib28
  article-title: Incidence and survival of patients with conjunctival melanoma in Europe
  publication-title: JAMA Ophthalmol
  doi: 10.1001/jamaophthalmol.2020.0531
– volume: 129
  start-page: 421
  issue: 4
  year: 2022
  ident: bib56
  article-title: Chromosome 3 and 8q aberrations in uveal melanoma show greater impact on survival in patients with light iris versus dark iris color
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2021.11.011
– volume: 21
  start-page: 7172
  issue: 19
  year: 2020
  ident: bib55
  article-title: Iris colour and the risk of developing uveal melanoma
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21197172
– volume: 99
  start-page: 1190
  issue: 5
  year: 2016
  ident: bib5
  article-title: Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing
  publication-title: Am J Hum Genet
  doi: 10.1016/j.ajhg.2016.09.008
– volume-title: Cancer Incidence in Five Continents, Vol. VII: IARC Scientific Publications, No. 143
  year: 1997
  ident: bib35
– volume-title: The Global Health Observatory
  year: 2013
  ident: bib54
– volume: 30
  start-page: 166
  issue: 2
  year: 2020
  ident: bib10
  article-title: Genome-wide study on uveal melanoma patients finds association to DNA repair gene TDP1
  publication-title: Melanoma Res
  doi: 10.1097/CMR.0000000000000641
– volume: 116
  start-page: 536
  issue: 3
  year: 2009
  ident: bib3
  article-title: The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2008.10.008
– volume: 105
  start-page: 61
  year: 2007
  ident: bib9
  article-title: Primary acquired melanosis of the conjunctiva: experience with 311 eyes
  publication-title: Trans Am Ophthalmol Soc
– volume-title: Cancer Incidence in Five Continents, Vol. VIII: IARC Scientific Publications, No. 155
  year: 2002
  ident: bib36
– volume-title: National, state and territory population
  year: 2022
  ident: bib49
– volume: 83
  start-page: 1664
  issue: 8
  year: 1998
  ident: bib1
  article-title: The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society
  publication-title: Cancer
  doi: 10.1002/(ISSN)1097-0142
– volume-title: Cancer Incidence in Five Continents
  year: 2017
  ident: bib40
  article-title: Chapter 4: Histological groups
– volume: 581
  start-page: 434
  issue: 7809
  year: 2020
  ident: bib61
  article-title: The mutational constraint spectrum quantified from variation in 141,456 humans
  publication-title: Nature
  doi: 10.1038/s41586-020-2308-7
– volume: 112
  start-page: 1599
  issue: 9
  year: 2005
  ident: bib4
  article-title: Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2005.04.020
– volume: 6
  start-page: 330
  issue: 3
  year: 2012
  ident: bib14
  article-title: DNA-based eye colour prediction across Europe with the IrisPlex system
  publication-title: Forensic Sci Int Genet
  doi: 10.1016/j.fsigen.2011.07.009
– volume: 7
  start-page: 98
  issue: 1
  year: 2013
  ident: bib57
  article-title: The HIrisPlex system for simultaneous prediction of hair and eye colour from DNA
  publication-title: Forensic Sci Int Genet
  doi: 10.1016/j.fsigen.2012.07.005
– volume: 9
  start-page: 926034
  year: 2022
  ident: bib22
  article-title: Trends in uveal melanoma presentation and survival during five decades: a nationwide survey of 3898 Swedish patients
  publication-title: Front Med (Lausanne)
  doi: 10.3389/fmed.2022.926034
– volume-title: Cancer Incidence in Five Continents, Vol. XI (electronic version)
  year: 2017
  ident: bib39
– volume: 31
  start-page: 615
  issue: 6
  year: 2022
  ident: bib30
  article-title: Incidence and survival of ocular melanoma in National Cancer Registry of Poland in 2010-2017
  publication-title: Adv Clin Exp Med
  doi: 10.17219/acem/146581
– year: 2001
  ident: bib47
  article-title: GPE Discussion Paper Series: No. 31: Age standardization of rates: A New WHO Standard.
– volume: 137
  start-page: 2060
  issue: 9
  year: 2015
  ident: bib44
  article-title: Cancer incidence in five continents: inclusion criteria, highlights from volume X and the global status of cancer registration
  publication-title: Int J Cancer
  doi: 10.1002/ijc.v137.9
– year: 2023
  ident: bib53
– volume: 5
  start-page: 195
  issue: 3
  year: 2019
  ident: bib26
  article-title: Uveal melanoma in Ireland
  publication-title: Ocul Oncol Pathol
  doi: 10.1159/000492391
– volume: 124
  start-page: 54
  issue: 1
  year: 2006
  ident: bib2
  article-title: The association between host susceptibility factors and uveal melanoma: a meta-analysis
  publication-title: Arch Ophthalmol
  doi: 10.1001/archopht.124.1.54
– volume: 135
  start-page: 800
  issue: 6
  year: 2003
  ident: bib33
  article-title: Conjunctival melanoma: is it increasing in the United States?
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(02)02288-2
– volume-title: Cancer Incidence in Five Continents, Vol. IX: IARC Scientific Publications, No. 160
  year: 2007
  ident: bib37
– volume: 15
  start-page: 547
  issue: 6
  year: 2006
  ident: bib50
  article-title: Efficient interval estimation for age-adjusted cancer rates
  publication-title: Stat Methods Med Res
  doi: 10.1177/0962280206070621
– volume-title: Cancer Incidence in Five Continents, Vol. X: IARC Scientific Publications, No. 164
  year: 2013
  ident: bib38
– volume: 114
  start-page: 302
  issue: 2
  year: 2022
  ident: bib12
  article-title: Different pigmentation risk loci for high-risk monosomy 3 and low-risk disomy 3 uveal melanomas
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/djab167
– volume: 93
  start-page: 1524
  issue: 11
  year: 2009
  ident: bib32
  article-title: Time trends in the incidence of conjunctival melanoma in Sweden
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjo.2009.157933
– volume: 20
  start-page: 1689
  issue: 10
  year: 1967
  ident: bib42
  article-title: Tumors of the eye and adnexa in Africans of Uganda
  publication-title: Cancer
  doi: 10.1002/(ISSN)1097-0142
– volume-title: Standard country or area codes for statistical use (Statistical Papers, Series M, No. 49 Rev. 4)
  year: 1999
  ident: bib46
– volume: 114
  start-page: 114
  issue: 1
  year: 2005
  ident: bib15
  article-title: International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20690
– volume: 526
  start-page: 68
  issue: 7571
  year: 2015
  ident: bib52
  article-title: A global reference for human genetic variation
  publication-title: Nature
  doi: 10.1038/nature15393
– volume: 6
  start-page: 1721
  year: 2020
  ident: bib60
  article-title: Population-based cancer registration in Sub-Saharan Africa: its role in research and cancer control
  publication-title: JCO Glob Oncol
  doi: 10.1200/GO.20.00294
– volume: 103
  start-page: 1872
  issue: 12
  year: 2019
  ident: bib24
  article-title: Uveal melanoma incidence trends in Canada: a national comprehensive population-based study
  publication-title: Br J Ophthalmol
– volume-title: Cancer Incidence in Five Continents, CI5plus: IARC Cancer Base No. 9
  year: 2018
  ident: bib43
– volume: 63
  start-page: 661
  issue: 6
  year: 1985
  ident: bib20
  article-title: Incidence of choroidal malignant melanoma in Finland in the years 1973-1980
  publication-title: Acta Ophthalmol (Copenh)
  doi: 10.1111/aos.1985.63.issue-6
– volume: 6
  start-page: 31191
  year: 2016
  ident: bib13
  article-title: Genetic markers of pigmentation are novel risk loci for uveal melanoma
  publication-title: Sci Rep
  doi: 10.1038/srep31191
– volume: 40
  start-page: 151
  issue: 5
  year: 2002
  ident: bib62
  article-title: Migration trends and migration policy in Europe
  publication-title: Int Migr
  doi: 10.1111/imig.2002.40.issue-5
– year: 1996
  ident: bib48
  article-title: Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050, U.S. Bureau of the Census, Current Population Reports, P25-1130
– volume: 114
  start-page: 2309
  issue: 12
  year: 2007
  ident: bib19
  article-title: Incidence of uveal melanoma in Europe
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2007.01.032
– volume: 104
  start-page: 23
  issue: 1
  year: 2020
  ident: bib29
  article-title: Incidence trends of conjunctival malignant melanoma in Canada
  publication-title: Br J Ophthalmol
  doi: 10.1136/bjophthalmol-2019-313977
– volume: 16
  start-page: e1009201
  issue: 12
  year: 2020
  ident: bib7
  article-title: Genomic and transcriptomic landscape of conjunctival melanoma
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1009201
– volume: 27
  start-page: 492
  issue: 5
  year: 2017
  ident: bib16
  article-title: Characteristics of melanoma in Japan: a nationwide registry analysis 2011-2013
  publication-title: Melanoma Res
  doi: 10.1097/CMR.0000000000000375
– volume: 260
  start-page: 1723
  issue: 5
  year: 2022
  ident: bib27
  article-title: The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015
  publication-title: Graefes Arch Clin Exp Ophthalmol
  doi: 10.1007/s00417-021-05317-7
– volume: 16
  start-page: 19
  issue: 1
  year: 2018
  ident: bib51
  article-title: Evaluation of stability of directly standardized rates for sparse data using simulation methods
  publication-title: Popul Health Metr
  doi: 10.1186/s12963-018-0177-1
– volume: 87
  start-page: 709
  issue: 9
  year: 1995
  ident: bib58
  article-title: Uveal melanomas in black patients: a case series and comparative review
  publication-title: J Natl Med Assoc
SSID ssj0021120
Score 2.5678403
Snippet The worldwide incidence of ocular melanoma (OM), uveal melanoma (UM), and conjunctival melanoma has last been reported on 15 years ago. Recently, light iris...
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 45
SubjectTerms Clinical and Epidemiologic Research
Title Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors
URI https://www.proquest.com/docview/2884184896
https://pubmed.ncbi.nlm.nih.gov/PMC10617638
Volume 64
WOSCitedRecordID wos001169492700010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1552-5783
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0021120
  issn: 1552-5783
  databaseCode: DOA
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLW6gRAvE59aGUxGQrxAShMnzs0joFU8sDGhwcoDipzEphFtUrVNGPwafirXcZImMKTxwEtkOc6Hek-v742PzyXkiRorcHw7sRS2LFcw14pASssBPo7tIIpYVXnu41v_5ASm0-B0MPjZ7IUp536WwcVFsPyvpsY-NLbeOvsP5m5vih3YRqPjEc2OxysZvqLHfEsTTYqMTclQHRG-M4TTYzkXWb6odmKhM1itajIcuofN7Nlp-mVRb0bKrIonh_Hoe80-n5i6PN1YtiPRUeIjlrPNTMwXRtNJA6pM10Wz5XKLn_PCsPW_tj2fRFn8-J7qsDaYoIMxjXk1Dl1ZIlr-8Cuc0qUJ_I-0cvF2kWqRmI1p57qYNDryUfdrhlPx4uqFmdoBe5gc-6a4TeOhjc55g0TW8bdGivLPaYDrheg0L9cj7o5sNjLj-nLbv02DLTmxSou4H-rLQ-6GNgtdb4dcc3wvgCZpr1N62wh_tm_dqLhy_0Xv6f2oZ5vK9Im4ncjm7BbZq1MS-tJA6TYZyOwOuXFcky7uks8tomiLKJorahBFG0RRRBTtIIpqRNHLEEU1omiNqHvkw-To7PUbq67KYcWMexsLhIpjiEApBhAHXsS1xFIUx7aTBEHEIWEc41Ip8CwG1470IgG2D57yPLzQZffJbpZncp9QNXZU5LpKeUzLFtnCUbYac8Ex63DGTA7J8-ZXC-Nasl5XTpmHl9poSJ62w5dGq-VvAx83JgjRm-olMpHJvFiHDoBrgwsBHxLo2aa9o9Zj75_J0lmly66_ruB0DQ-u-h4H5Ob2P_CQ7G5WhXxErsflJl2vDsmOP4XDCm-_ACj3sZo
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Worldwide+Incidence+of+Ocular+Melanoma+and+Correlation+With+Pigmentation-Related+Risk+Factors&rft.jtitle=Investigative+ophthalmology+%26+visual+science&rft.au=Wu%2C+Mike&rft.au=Yavuzyi%C4%9Fito%C4%9Flu%2C+Serdar&rft.au=Brosens%2C+Erwin&rft.au=Ramdas%2C+Wishal+D.&rft.date=2023-10-30&rft.issn=1552-5783&rft.volume=64&rft.issue=13&rft.spage=45&rft_id=info:doi/10.1167%2Fiovs.64.13.45&rft.externalDBID=n%2Fa&rft.externalDocID=10_1167_iovs_64_13_45
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1552-5783&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1552-5783&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1552-5783&client=summon